Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,450 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,542 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00294151 | Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer | unknown | Phase 3 | 30 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jul 13, 2007 | clinicaltrials |
| NCT00494039 | I-125 Versus Pd-103 for Low Risk Prostate Cancer | unknown | Phase 3 | 602 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 |
| clinicaltrials |
| NCT00494546 | High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer | completed | Phase 3 | 568 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00486499 | I-125 Versus Pd-103 for Medium Risk Prostate Cancer | unknown | Phase 3 | 660 | VA Puget Sound Health Care SystemFED | 1 | Jun 14, 2007 | clinicaltrials |
| NCT00080041 | Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors | completed | Phase 1 | 20 | Pharmacyclics LLC.INDUSTRY | 1 | May 15, 2007 | clinicaltrials |
| NCT00293696 | Casodex/Zoladex Biomarkers in Localised Prostate Cancer | completed | Phase 4 | 30 | Tampere UniversityOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00052000 | A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer | completed | Phase 1 | 29 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 1, 2007 | clinicaltrials |
| NCT00400894 | Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma | unknown | — | 750 | ProteoSys AGINDUSTRY | 0 | Feb 5, 2007 | clinicaltrials |
| NCT00200187 | A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery | completed | Phase 2 | 246 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00040586 | Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2 | completed | Phase 2 | — | BZL BiologicsINDUSTRY | 1 | Jan 22, 2007 | clinicaltrials |
| NCT00421265 | Active Surveillance for Prostate Cancer With Indolent Features | unknown | — | 150 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Jan 11, 2007 | clinicaltrials |
| NCT00072722 | Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC) | completed | Phase 2 | 36 | Celgene CorporationINDUSTRY | 1 | Dec 19, 2006 | clinicaltrials |
| NCT00132756 | Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 30 | Morton Plant Mease Health CareOTHER | 1 | Nov 8, 2006 | clinicaltrials |
| NCT00040170 | Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer | terminated | Phase 2 | 50 | TransgeneINDUSTRY | 1 | Nov 2, 2006 | clinicaltrials |
| NCT00100243 | Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy | completed | Phase 2 | 22 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00103623 | The Plenaxis® Experience Study | suspended | Phase 4 | 2,000 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00375687 | Investigation of Early Hormonotherapy Efficacy of Prostate Cancer | unknown | N/A | 61 | Kaunas University of MedicineOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00127088 | Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients | suspended | Phase 2 | 37 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00039793 | Massage Therapy for Cancer-Related Fatigue | completed | Phase 2 | 45 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00038662 | Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure | completed | Phase 2 | 200 | AbbottINDUSTRY | 2 | Aug 15, 2006 | clinicaltrials |
| NCT00263107 | Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. | completed | — | 270 | University of California, DavisOTHER | 1 | May 31, 2006 | clinicaltrials |
| NCT00188383 | Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy | unknown | Phase 1 / Phase 2 | 132 | University Health Network, TorontoOTHER | 1 | Mar 14, 2006 | clinicaltrials |
| NCT00103428 | Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 1 / Phase 2 | 69 | Cell GenesysINDUSTRY | 1 | Feb 2, 2006 | clinicaltrials |
| NCT00228124 | PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition | unknown | — | 300 | Ontario Cancer Research NetworkNETWORK | 1 | Jan 26, 2006 | clinicaltrials |
| NCT00167024 | Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Nov 28, 2005 | clinicaltrials |
| NCT00179738 | A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer. | terminated | Phase 2 | 40 | Celgene CorporationINDUSTRY | 1 | Nov 23, 2005 | clinicaltrials |
| NCT00215345 | A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer | unknown | Phase 2 | 66 | Department of Veterans Affairs, New JerseyFED | 1 | Sep 22, 2005 | clinicaltrials |
| NCT00218205 | A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer | unknown | Phase 2 | 28 | Department of Veterans Affairs, New JerseyFED | 1 | Sep 22, 2005 | clinicaltrials |
| NCT00208988 | A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening | completed | N/A | 250 | Emory UniversityOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00201630 | Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy | unknown | Phase 3 | 150 | New York Prostate InstituteOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00185029 | MR-Lymphography and Lymph Node Staging in Prostate Cancer | unknown | Phase 4 | 396 | Radboud University Medical CenterOTHER | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00164437 | CD-ROM Intervention for Prostate Cancer Screening | completed | Phase 2 / Phase 3 | 554 | Centers for Disease Control and PreventionFED | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00155025 | Family History in Prostate Cancer Patients in Taiwan | unknown | — | 1,500 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00140374 | Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer) | completed | Phase 1 / Phase 2 | 36 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140387 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) | completed | Phase 1 / Phase 2 | 20 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140400 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 50 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00122499 | A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer | completed | Phase 3 | — | Erasmus Medical CenterOTHER | 1 | Jul 27, 2005 | clinicaltrials |
| NCT00116155 | Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | — | Cell GenesysINDUSTRY | 0 | Jun 28, 2005 | clinicaltrials |
| NCT00006430 | A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA | unknown | Phase 1 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00035217 | Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program | completed | — | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00061126 | ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body | completed | Phase 2 | 50 | AbgenixINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jul 13, 2007source: clinicaltrials